Targeted elimination of mutant mitochondrial DNA in MELAS-iPSCs by mitoTALENs
Abstract Mitochondrial diseases are maternally inherited heterogeneous disorders that are primarily caused by mitochondrial DNA (mtDNA) mutations. Depending on the ratio of mutant to wild-type mtDNA, known as heteroplasmy, mitochondrial defects can result in a wide spectrum of clinical manifestation...
Main Authors: | Yi Yang, Han Wu, Xiangjin Kang, Yanhui Liang, Ting Lan, Tianjie Li, Tao Tan, Jiangyun Peng, Quanjun Zhang, Geng An, Yali Liu, Qian Yu, Zhenglai Ma, Ying Lian, Boon Seng Soh, Qingfeng Chen, Ping Liu, Yaoyong Chen, Xiaofang Sun, Rong Li, Xiumei Zhen, Yang Yu, Xiaoping Li, Yong Fan |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2018-01-01
|
Series: | Protein & Cell |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1007/s13238-017-0499-y |
Similar Items
-
Generation of corrected-hiPSC (USTCi001-A-1) from epilepsy patient iPSCs using TALEN-mediated editing of the SCN1A gene
by: Huifang Zhao, et al.
Published: (2020-07-01) -
Effects of mitoTALENs-Directed Double-Strand Breaks on Plant Mitochondrial Genomes
by: Shin-ichi Arimura
Published: (2021-01-01) -
Elimination of Mutant mtDNA by an Optimized mpTALEN Restores Differentiation Capacities of Heteroplasmic MELAS-iPSCs
by: Naoki Yahata, et al.
Published: (2021-03-01) -
The safety and effectiveness of genetically corrected iPSCs derived from β-thalassaemia patients in nonmyeloablative β-thalassaemic mice
by: Yexing Xian, et al.
Published: (2020-07-01) -
Osteochondral Tissue Chip Derived From iPSCs: Modeling OA Pathologies and Testing Drugs
by: Zixuan Lin, et al.
Published: (2019-12-01)